Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia-Reference-Cited by-同舟云学术

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

Published:2000-11 Issue:5 Volume:43 Page:768-776
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Price Vera H.,Roberts Janet L.,Hordinsky Maria,Olsen Elise A.,Savin Ronald,Bergfeld Wilma,Fiedler Virginia,Lucky Anne,Whiting David A.,Pappas Frances,Culbertson Jennifer,Kotey Paul,Meehan Alan,Waldstreicher Joanne

Publisher

Elsevier BV

Subject

Dermatology

Reference35 articles.

1. Androgenetic alopecia;Olsen,1994

2. Androgenetic alopecia;Frieden,1986

3. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex;Ludwig;Br J Dermatol,1977

4. The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women;Olsen;J Am Acad Dermatol,1999

5. Androgen metabolism as it affects hair growth in androgenetic alopecia;Kaufman;Dermatol Clin,1996

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidimensional assessment of adverse events of finasteride: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024;2024-08-22

2. Non-Scarring Alopecia in Females: A Comprehensive Review;EMJ Dermatology;2024-08-09

3. Comprehensive transcriptome profiling between balding and non-balding scalp of female pattern hair loss in Asian;Archives of Dermatological Research;2024-06-08

4. Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs;Drug Discovery Today;2024-06

5. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies;Journal of Clinical Medicine;2024-05-23